Evaluation of amorphous solid dispersion properties using thermal analysis techniques

Advanced Drug Delivery Reviews

Volumn 64, Issue 5, 2012, Pages 396-421

  Baird, Jared A ^a,b   Taylor, Lynne S ^a  

^a PURDUE UNIVERSITY   (United States)

^b ALLERGAN INC   (United States)

Author keywords

Calorimetry; Crystallization; Glass transition; Miscibility; Mobility

Indexed keywords

AMORPHOUS SOLIDS; ANALYTICAL APPROACH; ANALYTICAL METHOD; DESCRIPTORS; DIFFERENTIAL SCANNING CALORIMETRIES (DSC); DISSOLUTION RATES; KEY PARAMETERS; MOLECULAR MOBILITY; PHYSICOCHEMICAL PROPERTY; PRODUCT PERFORMANCE; SOLID DISPERSION; THERMAL ANALYSIS TECHNIQUES; THERMAL ANALYTICAL TECHNIQUES; THERMAL TECHNIQUES; WATER SOLUBLE COMPOUNDS;

AMORPHOUS MATERIALS; CALORIMETRY; CARRIER MOBILITY; CHARACTERIZATION; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; GLASS TRANSITION; SOLUBILITY; THERMOANALYSIS;

DISPERSIONS;

CELECOXIB; EXCIPIENT; FELODIPINE; FLURBIPROFEN; GRISEOFULVIN; INDOMETACIN; INSULIN; ITRACONAZOLE; PHENOBARBITAL; QUINAPRIL; RITONAVIR; TOLBUTAMIDE;

AMORPHOUS SOLID DISPERSION; AQUEOUS SOLUTION; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG SOLUBILITY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ENTHALPY; ENTROPY; FAST SCANNING DIFFERENTIAL SCANNING CALORIMETRY; FREEZE DRYING; GLASS TRANSITION TEMPERATURE; MELTING POINT; MICROTHERMAL ANALYSIS; MISCIBILITY; MOISTURE; MOLECULAR MOBILITY; MOLECULAR STABILITY; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHASE SEPARATION; PHASE TRANSITION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SOLID STATE; STORAGE TEMPERATURE; TEMPERATURE DEPENDENCE; THERMAL ANALYSIS; THERMODYNAMICS; THERMOSTABILITY; VISCOSITY;

CALORIMETRY; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DIFFERENTIAL THERMAL ANALYSIS; THERMODYNAMICS;

EID: 84858797264     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2011.07.009     Document Type: Review

References (253)

1. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997, 23:3-25.
2. Fahr A., Liu X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin. Drug Delivery 2007, 4:403-416.
3. Berge S.M., Bighley L.D., Monkhouse D.C. Pharmaceutical salts. J. Pharm. Sci. 1977, 66:1-19.
4. Rabinow B.E. Nanosuspensions in drug delivery. Nat. Rev. Drug Discovery 2004, 3:785-796.
5. Rautio J., Kumpulainen H., Heimbach T., Oliyai R., Oh D., Jarvinen T., Savolainen J. Prodrugs: design and clinical applications. Nat. Rev. Drug Discovery 2008, 7:255-270.
6. Loftsson T., Duchêne D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 2007, 329:1-11.
7. Vasconcelos T., Sarmento B., Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today 2007, 12:1068-1075.
8. Sekiguchi K., Obi N. Studies on absorption of eutectic mixture 1. Comparison of behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem. Pharm. Bull. 1961, 9:866-872.
9. Chiou W.L., Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 1971, 60:1281-1302.
10. Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50:47-60.
11. van Drooge D.J., Hinrichs W.L.J., Visser M.R., Frijlink H.W. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int. J. Pharm. 2006, 310:220-229.
12. Narayanaswamy O.S. A model of structural relaxation in glass. J. Am. Ceram. Soc. 1971, 54:491-498.
13. Turnbull D., Cohen M.H. Free-volume model of amorphous phase - glass transition. J. Chem. Phys. 1961, 34:120-125.
14. Gibbs J.H., Dimarzio E.A. Nature of the glass transition and the glassy state. J. Chem. Phys. 1958, 28:373-383.
15. Goldstein M. Viscous liquids and glass transition - a potential energy barrier picture. J. Chem. Phys. 1969, 51:3728-3739.
16. Bengtzelius U., Gotze W., Sjolander A. Dynamics of supercooled liquids and the glass-transition. J. Phys. C: Solid State Phys. 1984, 17:5915-5934.
17. Hancock B.C., Shamblin S.L., Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass-transition temperatures. Pharm. Res. 1995, 12:799-806.
18. Vyazovkin S., Dranca I. Effect of physical aging on nucleation of amorphous indomethacin. J. Phys. Chem. B 2007, 111:7283-7287.
19. Richardson M.J. Thermal analysis. Comprehensive Polymer Science 1989, Vol. 1:867-901. Pergamon Press, New York.
20. Ford J.L., Timmins P. Pharmaceutical thermal analysis: techniques and applications 1989, John Wiley & Sons, New York.
21. Richardson M.J., Savill N.G. Derivation of accurate glass-transition temperatures by differential scanning calorimetry. Polymer 1975, 16:753-757.
22. Moynihan C.T., Easteal A.J., Wilder J., Tucker J. Dependence of glass-transition temperature on heating and cooling rate. J. Phys. Chem. 1974, 78:2673-2677.
23. Six K., Berghmans H., Leuner C., Dressman J., Van Werde K., Mullens J., Benoist L., Thimon M., Meublat L., Verreck G., Peeters J., Brewster M., Van den Mooter G. Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, part II. Pharm. Res. 2003, 20:1047-1054.
24. Shmeis R.A., Wang Z.R., Krill S.L. A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions, part I: a comparative analysis by thermally stimulated depolarization current and differential scanning calorimetry. Pharm. Res. 2004, 21:2025-2030.
25. Brown M.E. Handbook of thermal analysis and calorimetry. Principles and Practice 1998, Elsevier, Amsterdam. P.K. Gallagher (Ed.).
26. Hiemenz P.C., Lodge T.P. Polymer Chemistry 2007, CRC Press, Boca Raton. second ed.
27. Matsumoto T., Zografi G. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinylacetate) in relation to indomethacin crystallization. Pharm. Res. 1999, 16:1722-1728.
28. Turnbull D. Under what conditions can a glass be formed. Contemp. Phys. 1969, 10:473-488.
29. Baird J.A., Van Eerdenbrugh B., Taylor L.S. A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J. Pharm. Sci. 2010, 99:3787-3806.
30. Craig D.Q.M., Royall P.G., Kett V.L., Hopton M.L. The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems. Int. J. Pharm. 1999, 179:179-207.
31. Tong P., Zografi G. Solid-state characteristics of amorphous sodium indomethacin relative to its free acid. Pharm. Res. 1999, 16:1186-1192.
32. Towler C.S., Li T.L., Wikstrom H., Remick D.M., Sanchez-Felix M.V., Taylor L.S. An investigation into the influence of counterion on the properties of some amorphous organic salts. Mol. Pharm. 2008, 5:946-955.
33. Gupta P., Kakumanu V.K., Bansal A.K. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm. Res. 2004, 21:1762-1769.
34. Ambike A.A., Mahadik K.R., Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low T-g drug: in vitro and in vivo evaluations. Pharm. Res. 2005, 22:990-998.
35. Bhattacharya S., Suryanarayanan R. Local mobility in amorphous pharmaceuticals-characterization and implications on stability. J. Pharm. Sci. 2009, 98:2935-2953.
36. Marsac P.J., Rumondor A.C.F., Nivens D.E., Kestur U.S., Stanciu L., Taylor L.S. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone). J. Pharm. Sci. 2010, 99:169-185.
37. Vasanthavada M., Tong W.Q., Joshi Y., Kislalioglu M.S. Phase behavior of amorphous molecular dispersions I: determination of the degree and mechanism of solid solubility. Pharm. Res. 2004, 21:1598-1606.
38. Khougaz K., Clas S.D. Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers. J. Pharm. Sci. 2000, 89:1325-1334.
39. Gupta P., Bansal A.K. Molecular interactions in celecoxib-PVP-meglumine amorphous system. J. Pharm. Pharmacol. 2005, 57:303-310.
40. Kalaiselvan R., Mohanta G.P., Manna P.K., Manavalan R. Inhibition of albendazole crystallization in poly(vinylpyrrolidone) solid molecular dispersions. Pharmazie 2006, 61:618-624.
41. Albers J., Alles R., Matthee K., Knop K., Nahrup J.S., Kleinebudde P. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion. Eur. J. Pharm. Biopharm. 2009, 71:387-394.
42. Gordon M., Taylor J.S. Ideal copolymers and the 2nd-order transitions of synthetic rubbers 1. Non-crystalline copolymers. J. Appl. Chem. 1952, 2:493-500.
43. Couchman P.R., Karasz F.E. Classical thermodynamic discussion of effect of composition on glass-transition temperatures. Macromolecules 1978, 11:117-119.
44. Marsac P.J., Konno H., Taylor L.S. A comparison of the physical stability of amorphous felodipine and nifedipine systems. Pharm. Res. 2006, 23:2306-2316.
45. Jenckel E., Heusch R. Die erniedrigung der einfriertemperatur organischer glaser durch losungsmittel. Kolloid Z. Z. Polym. 1953, 130:89-105.
46. Kwei T.K. The effect of hydrogen-bonding on the glass-transition temperatures of polymer mixtures. J. Polym. Sci. Part C: Polymer Letters 1984, 22:307-313.
47. Brekner M.J., Schneider H.A., Cantow H.J. Approach to the composition dependence of the glass-transition temperature of compatible polymer blends 1. Polymer 1988, 29:78-85.
48. Schneider H.A. Glass-transition behavior of compatible polymer blends. Polymer 1989, 30:771-779.
49. Couchman P.R. Interaction strength, nonrandom mixing, and the compositional variation of glass-transition temperatures. Macromolecules 1991, 24:5772-5774.
50. Lin A.A., Kwei T.K., Reiser A. On the physical meaning of the kwei equation for the glass-transition temperature of polymer blends. Macromolecules 1989, 22:4112-4119.
51. Lu X., Weiss R.A. Relationship between the glass-transition temperature and the interaction parameter of miscible binary polymer blends. Macromolecules 1992, 25:3242-3246.
52. Painter P.C., Graf J.F., Coleman M.M. Effect of hydrogen-bonding on the enthalpy of mixing and the composition dependence of the glass-transition temperature in polymer blends. Macromolecules 1991, 24:5630-5638.
53. Kalichevsky M.T., Jaroszkiewicz E.M., Blanshard J.M.V. A study of the glass-transition of amylopectin sugar mixtures. Polymer 1993, 34:346-358.
54. Pomposo J.A., Eguiazabal I., Calahorra E., Cortazar M. Glass-transition behavior and interactions in poly(p-vinylphenol) polymethacrylate blends. Polymer 1993, 34:95-102.
55. Lu Q., Zografi G. Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid, and PVP. Pharm. Res. 1998, 15:1202-1206.
56. Fukuoka E., Makita M., Yamamura S. Glassy state of pharmaceuticals 3. Thermal-properties and stability of glassy pharmaceuticals and their binary glass systems. Chem. Pharm. Bull. 1989, 37:1047-1050.
57. Konno H., Taylor L.S. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J. Pharm. Sci. 2006, 95:2692-2705.
58. Rumondor A.C.F., Ivanisevic I., Bates S., Alonzo D.E., Taylor L.S. Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharm. Res. 2009, 26:2523-2534.
59. Van den Mooter G., Wuyts M., Blaton N., Busson R., Grobet P., Augustijns P., Kinget R. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur. J. Pharm. Sci. 2001, 12:261-269.
60. Taylor L.S., Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 1997, 14:1691-1698.
61. Marsac P., Li T., Taylor L. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm. Res. 2009, 26:139-151.
62. Taylor L.S., Langkilde F.W., Zografi G. Fourier transform Raman spectroscopic study of the interaction of water vapor with amorphous polymers. J. Pharm. Sci. 2001, 90:888-901.
63. Hancock B.C., Zografi G. The relationship between the glass-transition temperature and the water-content of amorphous pharmaceutical solids. Pharm. Res. 1994, 11:471-477.
64. Nair R., Nyamweya N., Gonen S., Martinez-Miranda L.J., Hoag S.W. Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. Int. J. Pharm. 2001, 225:83-96.
65. Gashi Z., Censi R., Malaj L., Gobetto R., Mozzicafreddo M., Angeletti M., Masic A., Di Martino P. Differences in the interaction between aryl propionic acid derivatives and poly(vinylpyrrolidone) K30: a multi-methodological approach. J. Pharm. Sci. 2009, 98:4216-4228.
66. Andrews G.P., Abudiak O.A., Ones D.S. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. J. Pharm. Sci. 2010, 99:1322-1335.
67. Tong P., Zografi G. A study of amorphous molecular dispersions of indomethacin and its sodium salt. J. Pharm. Sci. 2001, 90:1991-2004.
68. Shamblin S.L., Huang E.Y., Zografi G. The effects of co-lyophilized polymeric additives on the glass transition temperature and crystallization of amorphous sucrose. J. Therm. Anal. 1996, 47:1567-1579.
69. Shamblin S.L., Taylor L.S., Zografi G. Mixing behavior of colyophilized binary systems. J. Pharm. Sci. 1998, 87:694-701.
70. Rumondor A.C.F., Marsac P.J., Stanford L.A., Taylor L.S. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Mol. Pharm. 2009, 6:1492-1505.
71. Crowley K.J., Zografi G. Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions. J. Pharm. Sci. 2002, 91:2150-2165.
72. Konno H., Taylor L.S. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture. Pharm. Res. 2008, 25:969-978.
73. Rumondor A.C.F., Taylor L.S. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture. Mol. Pharm. 2010, 7:477-490.
74. Vasanthavada M., Tong W.Q., Joshi Y., Kislalioglu M.S. Phase behavior of amorphous molecular dispersions II: role of hydrogen bonding in solid solubility and phase separation kinetics. Pharm. Res. 2005, 22:440-448.
75. McPhillips H., Craig D.Q.M., Royall P.G., Hill V.L. Characterisation of the glass transition of HPMC using modulated temperature differential scanning calorimetry. Int. J. Pharm. 1999, 180:83-90.
76. Lu Q., Zografi G. Properties of citric acid at the glass transition. J. Pharm. Sci. 1997, 86:1374-1378.
77. McNeill I.C., Sadeghi S.M.T. Thermal-stability and degradation mechanisms of poly(acrylic acid) and its salts 1. Poly(acrylic acid). Polym. Degrad. Stab. 1990, 29:233-246.
78. Lai H.L., Pitt K., Craig D.Q.M. Characterisation of the thermal properties of ethylcellulose using differential scanning and quasi-isothermal calorimetric approaches. Int. J. Pharm. 2010, 386:178-184.
79. Bairamov D.F., Feldstein M.M., Lebedeva T.L., Chalykh A.E., Siegel R.A. Proceedings of the Int. Symp. Cont. Rel. Bio. Mat. 2001, 381.
80. Taylor L.S., Zografi G. Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures. J. Pharm. Sci. 1998, 87:1615-1621.
81. Shamblin S.L., Tang X.L., Chang L.Q., Hancock B.C., Pikal M.J. Characterization of the time scales of molecular motion in pharmaceutically important glasses. J. Phys. Chem. B 1999, 103:4113-4121.
82. Angell C.A. Landscapes with megabasins: polyamorphism in liquids and biopolymers and the role of nucleation in folding and folding diseases. Phys. D-Nonlin. Phenom. 1997, 107:122-142.
83. Abiad M.G., Campanella O.H., Carvajal M.T. Assessment of thermal transitions by dynamic mechanical analysis (DMA) using a novel disposable powder holder. Pharmaceutics 2010, 78-90.
84. Surana R., Pyne A., Suryanarayanan R. Effect of preparation method on physical properties of amorphous trehalose. Pharm. Res. 2004, 21:1167-1176.
85. Fukuoka E., Makita M., Nakamura Y. Glassy state of pharmaceuticals 4. Studies on glassy pharmaceuticals by thermomechanical analysis. Chem. Pharm. Bull. 1989, 37:2782-2785.
86. Aso Y., Yoshioka S., Kojima S. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions. J. Pharm. Sci. 2004, 93:384-391.
87. Kakumanu V.K., Bansal A.K. Enthalpy relaxation studies of celecoxib amorphous mixtures. Pharm. Res. 2002, 19:1873-1878.
88. Miyazaki T., Yoshioka S., Aso Y., Kojima S. Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. J. Pharm. Sci. 2004, 93:2710-2717.
89. Yoshioka S., Miyazaki T., Aso Y. Beta-relaxation of insulin molecule in lyophilized formulations containing trehalose or dextran as a determinant of chemical reactivity. Pharm. Res. 2006, 23:961-966.
90. Li J.J., Guo Y.S., Zografi G. The solid-state stability of amorphous quinapril in the presence of beta-cyclodextrins. J. Pharm. Sci. 2002, 91:229-243.
91. Hancock B.C., Zograf G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 1997, 86:1-12.
92. Yoshioka S., Aso Y. Correlations between molecular mobility and chemical stability during storage of amorphous pharmaceuticals. J. Pharm. Sci. 2007, 96:960-981.
93. Alig I., Braun D., Lagendorf R., Voigt M., Wendorff J.H. Simultaneous ageing and crystallization processes within the glassy state of a low molecular weight substance. J. Non-Cryst. Solids 1997, 221:261-264.
94. Bhugra C., Shmeis R., Krill S.L., Pikal M.J. Prediction of onset of crystallization from experimental relaxation times. II. Comparison between predicted and experimental onset times. J. Pharm. Sci. 2008, 97:455-472.
95. Vyazovkin S., Dranca I. Physical stability and relaxation of amorphous indomethacin. J. Phys. Chem. B 2005, 109:18637-18644.
96. Hancock B.C., Dupuis Y., Thibert R. Determination of the viscosity of an amorphous drug using thermomechanical analysis (TMA). Pharm. Res. 1999, 16:672-675.
97. Hodge I.M. Effects of annealing and prior history on enthalpy relaxation in glassy-polymers 6, Adam-Gibbs formulation of nonlinearity. Macromolecules 1987, 20:2897-2908.
98. Bohmer R., Ngai K.L., Angell C.A., Plazek D.J. Nonexponential relaxations in strong and fragile glass formers. J. Chem. Phys. 1993, 99:4201-4209.
99. Adam G., Gibbs J.H. On temperature dependence of cooperative relaxation properties in glass-forming liquids. Journal Of Chemical Physics 1965, 43:139-146.
100. Williams M.L., Landel R.F., Ferry J.D. Mechanical properties of substances of high molecular weight 19. The temperature dependence of relaxation mechanisms in amorphous polymers and other glass-forming liquids. J. Am. Chem. Soc. 1955, 77:3701-3707.
101. Kauzmann W. The nature of the glassy state and the behavior of liquids at low temperatures. Chem. Rev. 1948, 43:219-256.
102. Johari G.P., Astl G., Mayer E. Enthalpy relaxation of glassy water. J. Chem. Phys. 1990, 92:809-810.
103. Velikov V., Borick S., Angell C.A. The glass transition of water, based on hyperquenching experiments. Science 2001, 294:2335-2338.
104. Johari G.P., Goldstein M. Viscous liquids and glass transition 2. Secondary relaxations in glasses of rigid molecules. J. Chem. Phys. 1970, 53:2372-2388.
105. Johari G.P., Goldstein M. Molecular mobility in simple glasses. J. Phys. Chem. 1970, 74:2034-2035.
106. Johari G.P., Goldstein M. Viscous liquids and glass transition 3. Secondary relaxations in aliphatic alcohols and other nonrigid molecules. J. Chem. Phys. 1971, 55:4245-4252.
107. Paluch M., Pawlus S., Hensel-Bielowka S., Kaminski K., Psurek T., Rzoska S.J., Ziolo J., Roland C.M. Effect of glass structure on the dynamics of the secondary relaxation in diisobutyl and diisoctyl phthalates. Phys. Rev. B 2005, 72(224205):1-4.
108. Yoshioka S., Aso Y. A quantitative assessment of the significance of molecular mobility as a determinant for the stability of lyophilized insulin formulations. Pharm. Res. 2005, 22:1358-1364.
109. Sillescu H. Heterogeneity at the glass transition: a review. J. Non-Cryst. Solids 1999, 243:81-108.
110. Ediger M.D. Spatially heterogeneous dynamics in supercooled liquids. Annu. Rev. Phys. Chem. 2000, 51:99-128.
111. Wang L.M., Richert R. Glass transition dynamics and boiling temperatures of molecular liquids and their isomers. J. Phys. Chem. B 2007, 111:3201-3207.
112. Grzybowska K., Pawlus S., Mierzwa M., Paluch M., Ngai K.L. Changes of relaxation dynamics of a hydrogen-bonded glass former after removal of the hydrogen bonds. J. Chem. Phys. 2006, 125(144507):1-8.
113. Williams G., Watts D.C. Non-symmetrical dielectric relaxation behaviour arising from a simple empirical decay function. Trans. Far. Soc. 1970, 66:80-85.
114. Hancock B.C., Shamblin S.L. Molecular mobility of amorphous pharmaceuticals determined using differential scanning calorimetry. Thermochim. Acta 2001, 380:95-107.
115. Liu J.S., Rigsbee D.R., Stotz C., Pikal M.J. Dynamics of pharmaceutical amorphous solids: the study of enthalpy relaxation by isothermal microcalorimetry. J. Pharm. Sci. 2002, 91:1853-1862.
116. Johari G.P., Kim S., Shanker R.M. Dielectric relaxation and crystallization of ultraviscous melt and glassy states of aspirin, ibuprofen, progesterone, and quinidine. J. Pharm. Sci. 2007, 96:1159-1175.
117. Kestur U.S., Lee H., Santiago D., Rinaldi C., Won Y.Y., Taylor L.S. Effects of the molecular weight and concentration of polymer additives, and temperature on the melt crystallization kinetics of a small drug molecule. Cryst. Growth Des. 2010, 10:3585-3595.
118. Andronis V., Zografi G. Molecular mobility of supercooled amorphous indomethacin, determined by dynamic mechanical analysis. Pharm. Res. 1997, 14:410-414.
119. K. Adrjanowicz, M. Paluch, K.L. Ngai, Determining the structural relaxation times deep in the glassy state of the pharmaceutical telmisartan, J. Phys-Condens. Matter 22 125902 (1-11).
120. Aso Y., Yoshioka S., Kojima S. Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and H-1 NMR relaxation times. J. Pharm. Sci. 2000, 89:408-416.
121. Carpentier L., Bourgeois L., Descamps M. Contribution of temperature modulated DSC (R) to the study of the molecular mobility in glass forming pharmaceutical systems. J. Therm. Anal. Calorim. 2002, 68:727-739.
122. Andronis V., Zografi G. The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity. Pharm. Res. 1998, 15:835-842.
123. Johari G.P., Shanker R.M. Calorimetric relaxation and the glass-liquid temperature range of acetaminophen-nifedipine alloys. J. Pharm. Sci. 2008, 97:3233-3244.
124. Correia N.T., Ramos J.J.M., Descamps M., Collins G. Molecular mobility and fragility in indomethacin: a thermally stimulated depolarization current study. Pharm. Res. 2001, 18:1767-1774.
125. Duddu S.P., Zhang G.Z., DalMonte P.R. The relationship between protein aggregation and molecular mobility below the glass transition temperature of lyophilized formulations containing a monoclonal antibody. Pharm. Res. 1997, 14:596-600.
126. Graeser K.A., Patterson J.E., Zeitler J.A., Gordon K.C., Rades T. Correlating thermodynamic and kinetic parameters with amorphous stability. Eur. J. Pharm. Sci. 2009, 37:492-498.
127. Korhonen O., Bhura C., Pikal M.J. Correlation between molecular mobility and crystal growth of amorphous phenobarbital and phenobarbital with polyvinylpyrrolidone and L-proline. J. Pharm. Sci. 2008, 97:3830-3841.
128. Vyazovkin S., Dranca I. Probing beta relaxation in pharmaceutically relevant glasses by using DSC. Pharm. Res. 2006, 23:422-428.
129. Shamblin S.L., Zografi G. Enthalpy relaxation in binary amorphous mixtures containing sucrose. Pharm. Res. 1998, 15:1828-1834.
130. Mao C., Chamarthy S.P., Byrn S.R., Pinal R. A calorimetric method to estimate molecular mobility of amorphous solids at relatively low temperatures. Pharm. Res. 2006, 23:2269-2276.
131. Kawakami K., Pikal M.J. Calorimetric investigation of the structural relaxation of amorphous materials: evaluating validity of the methodologies. J. Pharm. Sci. 2005, 94:948-965.
132. Mao C., Chamarthy S.P., Pinal R. Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach. Pharm. Res. 2006, 23:1906-1917.
133. Shamblin S.L., Hancock B.C., Dupuis Y., Pikal M.J. Interpretation of relaxation time constants for amorphous pharmaceutical systems. J. Pharm. Sci. 2000, 89:417-427.
134. Luthra S.A., Hodge I.M., Pikal M.J. Investigation of the impact of annealing on global molecular mobility in glasses: optimization for stabilization of amorphous pharmaceuticals. J. Pharm. Sci. 2008, 97:3865-3882.
135. Bhugra C., Shmeis R., Krill S.L., Pikal M.J. Predictions of onset of crystallization from experimental relaxation times I-Correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition. Pharm. Res. 2006, 23:2277-2290.
136. Kawakami K., Ida Y. Direct observation of the enthalpy relaxation and the recovery processes of maltose-based amorphous formulation by isothermal microcalorimetry. Pharm. Res. 2003, 20:1430-1436.
137. Simon G.P. Dielectric-relaxation spectroscopy of thermoplastic polymers and blends. Mater. Forum 1994, 18:235-264.
138. He R., Craig D.Q.M. An investigation into the thermal behaviour of an amorphous drug using low frequency dielectric spectroscopy and modulated temperature differential scanning calorimetry. J. Pharm. Pharmacol. 2001, 53:41-48.
139. Correia N.T., Alvarez C., Ramos J.J.M., Descamps M. The beta-alpha branching in D-sorbitol as studied by thermally stimulated depolarization currents (TSDC). J. Phys. Chem. B 2001, 105:5663-5669.
140. Bhugra C., Shmeis R., Krill S.L., Pikal M.J. Different measures of molecular mobility: comparison between calorimetric and thermally stimulated current relaxation times below T-g and correlation with dielectric relaxation times above T-g. J. Pharm. Sci. 2008, 97:4498-4515.
141. Nikonorova N.A., Borisova T.I., Barmatov E.B., Pebalk D.A., Calleja R.D. Molecular mobility of CU(II)-containing liquid crystalline ionomers: dielectric relaxation and thermally stimulated depolarization currents. Polymer 2004, 45:1555-1562.
142. Spall S., Goodwin A.A., Zipper M.D., Simon G.P. Molecular dynamics in a miscible polyester blend. J. Polym. Sci. Part B: Polym. Phys. 1996, 34:2419-2431.
143. Caron V., Bhugra C., Pikal M.J. Prediction of onset of crystallization in amorphous pharmaceutical systems: phenobarbital, nifedipine/PVP, and phenobarbital/PVP. J. Pharm. Sci. 2010, 99:3887-3900.
144. Aso Y., Yoshioka S., Kojima S. Explanation of the crystallization rate of amorphous nifedipine and phenobarbital from their molecular mobility as measured by C-13 nuclear magnetic resonance relaxation time and the relaxation time obtained from the heating rate dependence of the glass transition temperature. J. Pharm. Sci. 2001, 90:798-806.
145. Forster A., Apperley D., Hempenstall J., Lancaster R., Rades T. Investigation of the physical stability of amorphous drug and drug/polymer melts using variable temperature solid state NMR. Pharmazie 2003, 58:761-762.
146. Aso Y., Yoshioka S., Miyazaki T., Kawanishi T. Feasibility of F-19 NMR for assessing the molecular mobility of flufenamic acid in solid dispersions. Chem. Pharm. Bull. 2009, 57:61-64.
147. Angell C.A. Relaxation in liquids, polymers and plastic crystals - strong fragile patterns and problems. J. Non-Cryst. Solids 1991, 131:13-31.
148. Yoshioka M., Hancock B.C., Zografi G. Crystallization of indomethacin from the amorphous state below and above its glass-transition temperature. J. Pharm. Sci. 1994, 83:1700-1705.
149. Dibenedetto A.T. Prediction of the glass-transition temperature of polymers - A model based on the principle of corresponding states. J. Polym. Sci. Part B: Polym. Phys. 1987, 25:1949-1969.
150. Fujara F., Geil B., Sillescu H., Fleischer G. Translational and rotational diffusion in supercooled orthoterphenyl close to the glass-transition. Z. Phys. B: Condens. Matter 1992, 88:195-204.
151. Mapes M.K., Swallen S.F., Ediger M.D. Self-diffusion of supercooled o-terphenyl near the glass transition temperature. J. Phys. Chem. B 2006, 110:507-511.
152. Ehlich D., Sillescu H. Tracer diffusion at the glass-transition. Macromolecules 1990, 23:1600-1610.
153. Douglas J.F., Leporini D. Obstruction model of the fractional Stokes-Einstein relation in glass-forming liquids. J. Non-Cryst. Solids 1998, 235:137-141.
154. Ediger M.D., Harrowell P., Yu L. Crystal growth kinetics exhibit a fragility-dependent decoupling from viscosity. J. Chem. Physics 2008, 128(034709):1-6.
155. Greet R.J., Turnbull D. Glass transition in o-terphenyl. J. Chem. Phys. 1967, 46:1243-1251.
156. Hikima T., Adachi Y., Hanaya M., Oguni M. Determination of potentially homogeneous-nucleation-based crystallization in o-terphenyl and an interpretation of the nucleation-enhancement mechanism. Phys. Rev. B 1995, 52:3900-3908.
157. Sun Y., Xi H.M., Ediger M.D., Richert R., Yu L. Diffusion-controlled and "diffusionless" crystal growth near the glass transition temperature: relation between liquid dynamics and growth kinetics of seven ROY polymorphs. J. Chem. Phys. 2009, 131(074506):1-9.
158. Sun Y., Xi H.M., Chen S., Ediger M.D., Yu L. Crystallization near glass transition: transition from diffusion-controlled to diffusionless crystal growth studied with seven polymorphs. J. Phys. Chem. B 2008, 112:5594-5601.
159. Tombari E., Ferrari C., Johari G.P., Shanker R.M. Calorimetric relaxation in pharmaceutical molecular glasses and its utility in understanding their stability against crystallization. J. Phys. Chem. B 2008, 112:10806-10814.
160. Ishida H., Wu T.A., Yu L.A. Sudden rise of crystal growth rate of nifedipine near T-g without and with polyvinylpyrrolidone. J. Pharm. Sci. 2007, 96:1131-1138.
161. Duddu S.P., Sokoloski T.D. Dielectric analysis in the characterization of amorphous pharmaceutical solids 1. Molecular mobility in poly(vinylpyrrolidone) water-systems in the glassy state. J. Pharm. Sci. 1995, 84:773-776.
162. Kararli T.T., Catalano T. Stabilization of misoprostol with hydroxypropyl methylcellulose (hpmc) against degradation by water. Pharm. Res. 1990, 7:1186-1189.
163. Tong P., Zografi G. Effects of water vapor absorption on the physical and chemical stability of amorphous sodium indomethacin. AAPS PharmSci 2004, 5.
164. Rumondor A.C.F., Jackson M.J., Taylor L.S. Effects of moisture on the growth rate of felodipine crystals in the presence and absence of polymers. Cryst. Growth Des. 2009, 10:747-753.
165. Miller D.P., Lechuga-Ballesteros D. Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility. Pharm. Res. 2006, 23:2291-2305.
166. Aso Y., Yoshioka S., Zhang J., Zografi G. Effect of water on the molecular mobility of sucrose and poly(vinylpyrrolidone) in a colyophilized formulation as measured by C-13-NMR relaxation time. Chem. Pharm. Bull. 2002, 50:822-826.
167. Paluch M., Roland C.M., Pawlus S., Ziolo J., Ngai K.L. Does the arrhenius temperature dependence of the Johari-Goldstein relaxation persist above T(g)?. Phys. Rev. Letter 2003, 91(115701):1-4.
168. Ivanisevic I. Physical stability studies of miscible amorphous solid dispersions. J. Pharm. Sci. 2010, 99:4005-4012.
169. Patterson D. Polymer compatibility with and without a solvent. Polym. Eng. Sci. 1982, 22:64-73.
170. Walsh D.J., Rostami S. The miscibility of high polymers - The role of specific interactions. Adv. Polym. Sci. 1985, 70:119-169.
171. Marsac P.J., Shamblin S.L., Taylor L.S. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm. Res. 2006, 23:2417-2426.
172. Dong J., Ozaki Y., Nakashima K. Infrared, Raman, and near-infrared spectroscopic evidence for the coexistence of various hydrogen-bond forms in poly(acrylic acid). Macromolecules 1997, 30:1111-1117.
173. Nyamweya N., Hoag S.W. Assessment of polymer-polymer interactions in blends of HPMC and film forming polymers by modulated temperature differential scanning calorimetry. Pharm. Res. 2000, 17:625-631.
174. Forster A., Hempenstall J., Tucker I., Rades T. Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int. J. Pharm. 2001, 226:147-161.
175. Six K., Murphy J., Weuts I., Craig D.Q.M., Verreck G., Peeters J., Brewster M., Van den Mooter G. Identification of phase separation in solid dispersions of itraconazole and Eudragit (R) E100 using microthermal analysis. Pharm. Res. 2003, 20:135-138.
176. Six K., Verreck G., Peeters J., Brewster M., Van den Mooter G. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. J. Pharm. Sci. 2004, 93:124-131.
177. Pouchly J., Patterson D. Polymers in mixed solvents. Macromolecules 1976, 9:574-579.
178. Robard A., Patterson D., Delmas G. Delta-chi effect and polystyrene poly(vinyl methyl-ether) compatibility in solution. Macromolecules 1977, 10:706-708.
179. ten Brinke G., Oudhuis L., Ellis T. Thermal characterization of multi-component systems by enthalpy relaxation. Thermochim. Acta 1994, 238:75-98.
180. Utracki L.A. Glass transition temperature in polymer blends. Adv. Polym. Technol. 1985, 5:33-39.
181. Newman A., Engers D., Bates S., Ivanisevic I., Kelly R.C., Zografi G. Characterization of amorphous api:polymer mixtures using X-ray powder diffraction. J. Pharm. Sci. 2008, 97:4840-4856.
182. Aso Y., Yoshioka S., Miyazaki T., Kawanishi T., Tanaka K., Kitamura S., Takakura A., Hayashi T., Muranushi N. Miscibility of nifedipine and hydrophilic polymers as measured by H-1-NMR spin-lattice relaxation. Chem. Pharm. Bull. 2007, 55:1227-1231.
183. Pham T.N., Watson S.A., Edwards A.J., Chavda M., Clawson J.S., Strohmeier M., Vogt F.G. Analysis of amorphous solid dispersions using 2D solid-state NMR and 1H T1 relaxation measurements. Mol. Pharm. 2010, 7:1667-1691.
184. Padilla A.M., Ivanisevic I., Yang Y., Engers D., Bogner R.H., Pikal M.J. The study of phase separation in amorphous freeze-dried systems. part I: Raman mapping and computational analysis of XRPD data in model polymer systems. J. Pharm. Sci. 2011, 206-222.
185. Janssens S., De Zeure A., Paudel A., Van Humbeeck J., Rombaut P., Van den Mooter G. Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and eudragit E100. Pharm. Res. 2010, 27:775-785.
186. Shultz A.R., Young A.L. DSC on freeze-dried poly(methyl methacrylate)-polystyrene blends. Macromolecules 1980, 13:663-668.
187. Paudel A., Van Humbeeck J., Van den Mooter G. Theoretical and experimental investigation on the solid solubility and miscibility of naproxen in poly(vinylpyrrolidone). Mol. Pharm. 2010, 7:1133-1148.
188. Wiranidchapong C., Tucker I.G., Rades T., Kulvanich P. Miscibility and interactions between 17-estradiol and eudragit (R) RS in solid dispersion. J. Pharm. Sci. 2008, 97:4879-4888.
189. Tao J., Sun Y., Zhang G.G.Z., Yu L. Solubility of small-molecule crystals in polymers: d-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA. Pharm. Res. 2009, 26:855-864.
190. Sun Y., Tao J., Zhang G.G.Z., Yu L. Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc. J. Pharm. Sci. 2010, 99:4023-4031.
191. Weeks N.E., Karasz F.E., Macknight W.J. Enthalpy of mixing of poly(2,6-dimethyl phenylene oxide) and polystyrene. J. Appl. Phys. 1977, 48:4068-4071.
192. Marsac P.J., Taylor L.S. Thermodynamics of mixing drugs and polymers. AAPS J. 2008, 10(S2).
193. Righetti M.C., Cardelli C., Scalari M., Tombari E., Conti G. Thermodynamics of mixing of poly(vinyl chloride) and poly(ethylene-co-vinyl acetate). Polymer 2002, 43:5035-5042.
194. Brunacci A., Pedemonte E., Cowie J.M.G., McEwen I.J. The thermodynamics of mixing of polystyrene and poly (α-methylstyrene) from a calorimetric viewpoint. Polymer 1994, 35:2893-2896.
195. Law D., Krill S.L., Schmitt E.A., Fort J.J., Qiu Y.H., Wang W.L., Porter W.R. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions. J. Pharm. Sci. 2001, 90:1015-1025.
196. Weuts I., Kempen D., Decorte A., Verreck G., Peeters J., Brewster M., Van den Mooter G. Phase behaviour analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64. Eur. J. Pharm. Sci. 2004, 22:375-385.
197. Van Eerdenbrugh B., Taylor L.S. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation. Mol. Pharm. 2010, 7:1328-1337.
198. Green J.L., Ito K., Xu K., Angell C.A. Fragility in liquids and polymers: new, simple quantifications and interpretations. J. Phys. Chem. B 1999, 103:3991-3996.
199. Angell C.A. Relaxations in complex systems. National Technical Information Service 1985, U.S. Department of Commerce, Springfield, VA. K. Ngai, G.B. Wright (Eds.).
200. Crowley K.J., Zografi G. The use of thermal methods for predicting glass-former fragility. Thermochim. Acta 2001, 380:79-93.
201. Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv. Drug Delivery Rev. 2001, 48:27-42.
202. Zhou D.L., Zhang G.G.Z., Law D., Grant D.J.W., Schmitt E.A. Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility. J. Pharm. Sci. 2002, 91:1863-1872.
203. Kaushal A.M., Bansal A.K. Thermodynamic behavior of glassy state of structurally related compounds. Eur. J. Pharm. Biopharm. 2008, 69:1067-1076.
204. Zhou D.L., Grant D.J.W., Zhang G.G.Z., Law D., Schmitt E.A. A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses. J. Pharm. Sci. 2007, 96:71-83.
205. Gupta P., Chawla G., Bansal A.K. Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility. Mol. Pharm. 2004, 1:406-413.
206. Friesen D.T., Shanker R., Crew M., Smithey D.T., Curatolo W.J., Nightingale J.A.S. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol. Pharm. 2008, 5:1003-1019.
207. Barandiaran J.M., Colmenero J. Continuous cooling approximation for the formation of a glass. J. Non-Cryst. Solids 1981, 46:277-287.
208. Whichard G., Day D.E. Glass-formation and properties in the gallia-calcia system. J. Non-Cryst. Solids 1984, 66:477-487.
209. Cabral A.A., Cardoso A.A.D., Zanotto E.D. Glass-forming ability versus stability of silicate glasses. I. Experimental test. J. Non-Cryst. Solids 2003, 320:1-8.
210. Huang W., Ray C.S., Day D.E. Dependence of the critical cooling rate for lithium silicate glass on nucleating-agents. J. Non-Cryst. Solids 1986, 86:204-212.
211. Damian F., Blaton N., Augustijns P., Naesens L., Balzarini J., Kinget R., Van den Mooter G. Thermal characterization of the antiviral drug UC-781 and stability of its glass. Thermochim. Acta 2001, 366:61-69.
212. Bhugra C., Pikal M.J. Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state. J. Pharm. Sci. 2008, 97:1329-1349.
213. Marsac P.J., Konno H., Rumondor A.C.F., Taylor L.S. Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water. Pharm. Res. 2008, 25:647-656.
214. Salekigerhardt A., Zografi G. Nonisothermal and isothermal crystallization of sucrose from the amorphous state. Pharm. Res. 1994, 11:1166-1173.
215. Bhugra C., Shmeis R., Pikal M.J. Role of mechanical stress in crystallization and relaxation behavior of amorphous indomethacin. J. Pharm. Sci. 2008, 97:4446-4458.
216. Schroers J., Masuhr A., Johnson W.L., Busch R. Pronounced asymmetry in the crystallization behavior during constant heating and cooling of a bulk metallic glass-forming liquid. Phys. Rev. B 1999, 60:11855-11858.
217. Shah B., Kakumanu V.K., Bansal A.K. Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids. J. Pharm. Sci. 2006, 95:1641-1665.
218. Andronis V., Zografi G. Crystal nucleation and growth of indomethacin polymorphs from the amorphous state. J. Non-Cryst. Solids 2000, 271:236-248.
219. Strydom S., Liebenberg W., Yu L., de Villiers M. The effect of temperature and moisture on the amorphous-to-crystalline transformation of stavudine. Int. J. Pharm. 2009, 379:72-81.
220. Zhu L., Wong L., Yu L. Surface-enhanced crystallization of amorphous nifedipine. Mol. Pharm. 2008, 5:921-926.
221. Wu T., Yu L. Surface crystallization of indomethacin below T-g. Pharm. Res. 2006, 23:2350-2355.
222. Kestur U.S., Taylor L.S. Role of polymer chemistry in influencing crystal growth rates from amorphous felodipine. Cryst. Eng. Comm. 2010, 12:2390-2397.
223. Clas S.D., Faizer R., Oconnor R.E., Vadas E.B. Quantification of crystallinity in blends of lyophilized and crystalline MK-0591 using X-ray-powder diffraction. Int. J. Pharm. 1995, 121:73-79.
224. Rumondor A.C.F., Taylor L.S. Application of Partial Least-Squares (PLS) modeling in quantifying drug crystallinity in amorphous solid dispersions. Int. J. Pharm. 2010, 398:155-160.
225. Chieng N., Rehder S., Saville D., Rades T., Aaltonen J. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction. J. Pharm. Biomed. Anal. 2009, 49:18-25.
226. Surana R., Suryanarayanan R. Quantitation of crystallinity in substantially amorphous pharmaceuticals and study of crystallization kinetics by X-ray powder diffractometry. Powder Diffr. 2000, 15:2-6.
227. Balani P.N., Wong S.Y., Ng W.K., Widjaja E., Tan R.B.H., Chan S.Y. Influence of polymer content on stabilizing milled amorphous salbutamol sulphate. Int. J. Pharm. 2010, 391:125-136.
228. Thybo P., Pedersen B.L., Hovgaard L., Holm R., Mullertz A. Characterization and physical stability of spray dried solid dispersions of probucol and PVP-K30. Pharm. Dev. Technol. 2008, 13:375-386.
229. Forster A., Hempenstall J., Tucker I., Rades T. The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion. Drug Dev. Ind. Pharm. 2001, 27:549-560.
230. Yoshihashi Y., Iijima H., Yonemochi E., Terada K. Estimation of physical stability of amorphous solid dispersion using differential scanning calorimetry. J. Therm. Anal. Calorim. 2006, 85:689-692.
231. Yoshihashi Y., Yonemochi E., Maeda Y., Terada K. Prediction of the induction period of crystallization of naproxen in solid dispersion using differential scanning calorimetry. J. Therm. Anal. Calorim. 2010, 99:15-19.
232. Guinot S., Leveiller F. The use of MTDSC to assess the amorphous phase content of a micronised drug substance. Int. J. Pharm. 1999, 192:63-75.
233. Miyazaki T., Yoshioka S., Aso Y. Physical stability of amorphous acetanilide derivatives improved by polymer excipients. Chem. Pharm. Bull. 2006, 54:1207-1210.
234. Yang J., Grey K., Doney J. An improved kinetics approach to describe the physical stability of amorphous solid dispersions. Int. J. Pharm. 2010, 384:24-31.
235. Wanapun D., Kestur U.S., Kissick D.J., Simpson G.J., Taylor L.S. Selective detection and quantitation of organic molecule crystallization by second harmonic generation microscopy. Anal. Chem. 2010, 82:5425-5432.
236. Gaisford S. Fast-scan differential scanning calorimetry. Eur. Pharm. Review 2008, 83-89.
237. Pijpers T.F.J., Mathot V.B.F., Goderis B., Scherrenberg R.L., van der Vegte E.W. High-speed calorimetry for the study of the kinetics of (de)vitrification, crystallization, and melting of macromolecules. Macromolecules 2002, 35:3601-3613.
238. Mathot V.B.F., Poel G.V., Pijpers T.F.J. Improving and speeding up the characterization of substances, materials, and products: benefits and potentials of high-speed DSC. Am. Lab. 2006, 38:21-25.
239. Saunders M., Podluii K., Shergill S., Buckton G., Royall P. The potential of high speed DSC (hyper-DSC) for the detection and quantification of small amounts of amorphous content in predominantly crystalline samples. Int. J. Pharm. 2004, 274:35-40.
240. Lappalainen M., Pitkanen I., Harjunen P. Quantification of low levels of amorphous content in sucrose by hyperDSC. Int. J. Pharm. 2006, 307:150-155.
241. Gramaglia D., Conway B.R., Kett V.L., Malcolm R.K., Batchelor H.K. High speed DSC (hyper-DSC) as a tool to measure the solubility of a drug within a solid or semi-solid matrix. Int. J. Pharm. 2005, 301:1-5.
242. Danley R.L., Caulfield P.A., Aubuchon S.R. A rapid-scanning differential scanning calorimeter. Am. Lab. 2008, 40:9-11.
243. Efremov M.Y., Olson E.A., Zhang M., Lai S.L., Schiettekatte F., Zhang Z.S., Allen L.H. Thin-film differential scanning nanocalorimetry: heat capacity analysis. Thermochim. Acta 2004, 412:13-23.
244. Gradys A., Sajkiewicz P., Minakov A.A., Adamovsky S., Schick C., Hashimoto T., Saijo K. Crystallization of polypropylene at various cooling rates. Mater. Sci. Eng. A 2005, 413:442-446.
245. Guns S., Kayaert P., Martens J.A., Van Humbeeck J., Mathot V., Pijpers T., Zhuravlev E., Schick C., Van den Mooter G. Characterization of the copolymer poly(ethyleneglycol-g-vinylalcohol) as a potential carrier in the formulation of solid dispersions. Eur. J. Pharm. Biopharm. 2010, 74:239-247.
246. Royall P.G., Kett V.L., Andrews C.S., Craig D.Q.M. Identification of crystalline and amorphous regions in low molecular weight materials using microthermal analysis. J. Phys. Chem. B 2001, 105:7021-7026.
247. Galop M. Study of pharmaceutical solid dispersions by microthermal analysis. Pharm. Res. 2005, 22:293-302.
248. Harding L., Wood J., Reading M., Craig D.Q.M. Two- and three-dimensional imaging of multicomponent systems using scanning thermal microscopy and localized thermomechanical analysis. Anal. Chem. 2007, 79:129-139.
249. Harding L., King W.P., Dai X., Craig D.Q.M., Reading M. Nanoscale characterisation and imaging of partially amorphous materials using local thermomechanical analysis and heated tip AFM. Pharm. Res. 2007, 24:2048-2054.
250. Hammiche A., Pollock H.M., Reading M., Claybourn M., Turner P.H., Jewkes K. Photothermal FT-IR spectroscopy: a step towards FT-IR microscopy at a resolution better than the diffraction limit. Appl. Spectrosc. 1999, 53:810-815.
251. Harding L., Qi S., Hill G., Reading M., Craig D.Q.M. The development of microthermal analysis and photothermal microspectroscopy as novel approaches to drug-excipient compatibility studies. Int. J. Pharm. 2008, 354:149-157.
252. Dai X., Moffat J.G., Mayes A.G., Reading M., Craig D.Q.M., Belton P.S., Grandy D.B. Thermal probe based analytical microscopy: thermal analysis and photothermal Fourier-transform infrared microspectroscopy together with thermally assisted nanosampling coupled with capillary electrophoresis. Anal. Chem. 2009, 81:6612-6619.
253. Kjoller K., Felts J.R., Cook D., Prater C.B., King W.P. High-sensitivity nanometer-scale infrared spectroscopy using a contact mode microcantilever with an internal resonator paddle. Nanotechnology 2010, 21:1-6.